Nutriband subsidiary, 4p therapeutics llc, conducts phase 1b clinical study for sorrento therapeutics, inc. on lymphatic etanercept delivery in rheumatoid arthritis patients with results to be presented at the 2022 american college of rheumatology confere
Orlando, fl / accesswire / october 26, 2022 / nutriband inc. (the "company") (nasdaq:ntrb) (nasdaq:ntrbw) today announced that its subsidiary, 4p therapeutics llc ("4p therapeutics"), has conducted a phase 1b clinical study for sorrento therapeutics, inc. ("sorrento") (nasdaq:srne) with results to be presented at the american college of rheumatology (acr) convergence 2022 conference on november 13, 2022 as a poster abstract entitled "lymphatic delivery of etanercept achieves significant improvements in rheumatoid arthritis disease measures at 50% of the standard dose for patients with an inadequate response to subcutaneous injections." "we are excited about these proof of concept clinical results and the development of sorrento's sofusa lymphatic delivery platform for treatment of autoimmune diseases such as rheumatoid arthritis to provide hope for those patients who do not respond adequately to conventional biologic injections," said alan smith, ph.d.
NTRB Ratings Summary
NTRB Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission